Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,999 public trials 648 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Recruiting

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

NCT06804655

Conditions
Astrocytoma, Brain (Nervous System) Cancers, Central Nervous System Neoplasms, +23 more
Locations
  • University Hospital Basel Basel, Basel-Landschaft, Switzerland
  • Cantonal Hospital St Gallen Sankt Gallen, Canton of St. Gallen, Switzerland
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
View Trial Details
Recruiting

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

NCT06838676

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +20 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Emory University/Children's Healthcare of Atlanta Atlanta, Georgia, United States
View all 20 locations
View Trial Details
Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

NCT06395103

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
Locations
  • Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
  • Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
View all 71 locations
View Trial Details
Recruiting

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

NCT07326566

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +19 more
Locations
  • University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 30 locations
View Trial Details

Related conditions